Skip to main content
. 2024 Feb 27;16(2):1632–1644. doi: 10.21037/jtd-22-1884

Table 2. Potential future steps in decreasing infectious disease complications among lung transplantation recipients.

A. Evaluation of the current situation
   Collection of microbiological data, including pathogens and their susceptibilities
   Variability in ID management among transplant centers
B. Inter- and intra-institutional cooperation
   Inter-institutional cooperation, including networking among transplant centers
   Intra-institutional cooperation
   Vaccination and prophylaxis protocols
   Development of institution-specific ID guidelines
   Transplant-specific antimicrobial stewardship programs
   Defining metrics
   Transplant recipient-specific antibiograms
   Handshake stewardship
C. Re-evaluation and modification
   Continuous & prospective collection of ID data to evaluate the effect of actions

ID, infectious diseases.